Tag Archives: RMD

high yield investments


It used to be that finding a decent yield in the stock market was easy.

Just seven years ago, all you had to do was buy an ETF in a sector that got income hounds’ hearts racing, like the Utilities Select SPDR ETF (XLU) and lock in an easy 4.48% payout:

The “Good Old Days” Are Over for Utility Fans

But do the same today, and you’ll get just 3.1% for your trouble, no thanks to the merciless rise in stocks (and shriveling of yields) driven by a decade of near-zero interest rates.

And sure, a 3.1% payout may still sound okay. It is, after all, 63% more than you’d get from your average S&P 500 dividend payer.

high yield investments: Qualstar Corporation(QBAK)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha) Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha) CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update. Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million. The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62. Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold. Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split. Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period. AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016. Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):

    Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line with today’s early effort. The market dared the bulls to play their hand, and as it turns out, they were bluffing. The sheer scope of the reversal bar in the meantime today confirms the downtrend.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggestedpreemptively shorting small cap data storage systems stockQualstar Corporation (NASDAQ: QBAK):

high yield investments: ResMed Inc.(RMD)

Advisors’ Opinion:


    Medical equipment maker ResMed (RMD) is another name that’s starting to look “toppy” after a bullish start to the year. RMD has more or less kept pace with the S&P 500 in 2014, climbing just over 11% from January to today — but shares started forming a long-term triple-top over the summer, and that setup is getting close to completion this fall.

    It’s worth noting that long-term price setups come with equally long term trading implications when they trigger.

    The triple-top that RMD is showing is a fairly rare pattern, but the trigger is pretty perfunctory: if shares break down below support at $48, then sellers are in control, and it’s time to unload them. Downside isn’t a foregone conclusion in ResMed, but this setup only gets invalidated if shares can close above their prior highs at $54.

high yield investments: Brown(n)

Advisors’ Opinion:

  • [By Arie Goren]

    On November 5, Oracle (NYSE:ORCL)confirmed that it has finally completed the acquisition of Netsuite (NYSE:N) for $9.3 billion in cash, or $109 per share that the company had initially offered. In my previous article about Oracle, I had suggested that the acquisition of NetSuite, the cloud business application software company, is a smart move by Oracle. What’s more, it is not paying an excessive price for the deal. In fact, Oracle insisted that it will not pay more than what it had first offered despite the resistance from T Rowe Price (NSDQ:TROW)which demanded $133 per share.

high yield investments: Corning Incorporated(GLW)

Advisors’ Opinion:

  • [By Frank DiPietro]

    When Corning Inc. (NYSE:GLW) reported earnings in late January, it committed to continue to reward stockholders handsomely. Its stock price has appreciated nicely over the past 12 months (up roughly 50%) and now it has reiterated its plan to buy back its own shares over the next three years and continue to pay its shareholders a growing dividend. Total cost to the company is projected by management to be at least $12.5 billion through 2019, including annual dividend increases projected to be more than 10%.

  • [By Laurie Kulikowski]

    We rate CORNING INC as a Buy with a ratings score of B. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company’s strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. 

  • [By Laurie Kulikowski]

    GLW’s debt-to-equity ratio is very low at 0.20 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Along with this, the company maintains a quick ratio of 3.30, which clearly demonstrates the ability to cover short-term cash needs.


  • [By Steve Symington]

    Corning’s (NYSE:GLW) cutting-edge glass technology can already be found everywhere from smartphones to LCD TVs, advanced optics systems, lab science equipment, and even the ceramic substrates and particulate filters underlying pollution control systems in millions of vehicles today.But Corning is ready to take its show on the road in a much more visible way.

  • [By Peter Graham]

    Back on December 5th of 2013, we added Corning (GLW) to our list around $16 and change. The stock ended up moving to a high of just over $25 per share early last year for roughly a 50% gain. Well, the stock has since come off again trading all the way back down to under $16 per share back in August of last year, before finding its way back up above $18 just yesterday. The context here is two-fold. First, the valuation metrics for GLW are once again suggesting another undervalued opportunity for a Company that is the clear leader in specialty glass and ceramics.

high yield investments: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

Best Canadian Stocks To Buy For 2018

It looks like activist investor Bill Ackman is putting the proceeds from his Canadian Pacific (NYSE:CP) sale to work in a completely different space. Ackman’s Pershing Square Capital now has a 9.9% stake in Chipotle (NYSE:CMG). Ackman is now its second largest shareholder.

The writing was on the wall as well, where Ackman has gone out of his way to mention his love of CMG. Recall that Ackman told a story about a meeting with Valeant (NYSE:VRX) and Mike Pearson, where instead of eating the catered VRX food, he had Mike’s assistant fetch him a Chipotle burrito.

As we noted last month, CMG is a prime activist investor target, it was just a matter of time. However, much of the media and small research shops are taking Ackman to task, where it looks as if peak Bill Ackman is upon us. Much of the articles showing up on Seeking Alpha are negative. Ackman’s run in with Valeant and his battle with Carl Icahn over Herbalife (NYSE:HLF) has created a lot negativity aroun d the Pershing Square name.

Best Canadian Stocks To Buy For 2018: ResMed Inc.(RMD)

Advisors’ Opinion:


    Medical equipment maker ResMed (RMD) is another name that’s starting to look “toppy” after a bullish start to the year. RMD has more or less kept pace with the S&P 500 in 2014, climbing just over 11% from January to today — but shares started forming a long-term triple-top over the summer, and that setup is getting close to completion this fall.

    It’s worth noting that long-term price setups come with equally long term trading implications when they trigger.

    The triple-top that RMD is showing is a fairly rare pattern, but the trigger is pretty perfunctory: if shares break down below support at $48, then sellers are in control, and it’s time to unload them. Downside isn’t a foregone conclusion in ResMed, but this setup only gets invalidated if shares can close above their prior highs at $54.

Best Canadian Stocks To Buy For 2018: Zimmer Biomet Holdings, Inc.(ZBH)

Advisors’ Opinion:

  • [By Keith Speights]

    The three top dividend stocks in the dentistry industry are Patterson Companies (NASDAQ:PDCO), Zimmer Biomet Holdings (NYSE:ZBH), and Danaher (NYSE:DHR). But two of these, Zimmer Biomet and Danaher, pay out only small dividends.


    For the details of Focused Investors LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Focused+Investors+LLC

    These are the top 5 holdings of Focused Investors LLCZimmer Biomet Holdings Inc (ZBH) – 1,433,300 shares, 6.32% of the total portfolio. Shares added by 23.22%CVS Health Corp (CVS) – 2,120,700 shares, 6.01% of the total portfolio. Shares added by 19.73%Johnson & Johnson (JNJ) – 1,285,900 shares, 5.78% of the total portfolio. Shares reduced by 0.67%American Express Co (AXP) – 1,990,300 shares, 5.68% of the total portfolio. Shares reduced by 0.33%Anthem Inc (ANTM) – 944,800 shares, 5.64% of the total portfolio. Sh

Best Canadian Stocks To Buy For 2018: Staples, Inc.(SPLS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Staples (SPLS) tumbled to the bottom of the S&P 500 today after releasing earnings today.

    Getty Images

    Staples dropped 5.2% to $8.49 at 4:45 p.m. today, while the S&P 500 rose 0.1% to 2,364.87.

    Staples reported a profit of 25 cents a share, missing forecasts for 26 cents a share, on sales of $4.6 billion, missing expectations for $5.04 billion. Staples said it would earn from 15 cents to 18 cents in the first quarter of 2017, while analysts had been predicting 17 cents. Staples also said it would close 70 stores in 2017 after closing 48 in 2016.

    Staples market capitalization fell to $5.5 billion today from $5.8 billion yesterday.

  • [By Casey Wilson]

    Struggling office supply giant Staples Inc. (Nasdaq: SPLS) may have just found a way out of its imminent demise… Sort of.

    The Wall Street Journal reported today (April 4) that Staples is exploring a sale and is “in talks with potential private-equity bidders,” roughly one year after a federal judge blocked its proposed $6 billion tie-up with Office Depot Inc. (Nasdaq: ODP).

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Staples, Inc. (NASDAQ: SPLS) which traded down 5.3% at $8.49. The stocks 52-week range is $7.24 to $11.37. Volume was more than double the daily average of 6.05 million shares. The company saw its shares drop following its most recent earnings report.

  • [By Brian Feroldi, Anders Bylund, and Cory Renauer]

    Read on to see why a team of Fools think thatStaples (NASDAQ:SPLS), Mattel (NASDAQ:MAT), and GNC Holdings (NYSE:GNC) are all high-yield stocks that should be avoided.

  • [By Jeremy Bowman]

    Staples Inc(NASDAQ:SPLS) stock has been on a tear over the last few days amid rumors of a potential buyout.According toThe Wall Street Journal, the company is in talks with private-equity firms to sell itself after regulators blew up its planned merger withOffice Depot(NASDAQ:ODP)last year.

  • [By Ben Levisohn]

    Staples (SPLS) soared to the top of the S&P 500 today on reports that the office-supplies retailer was considering selling itself.

    Agence France-Presse/Getty Images

    Staples gained 9.8% to $9.51 today, while the S&P 500 ticked up 0.1% to 2,360.16.

    CFRA’s Efraim Levy doesn’t see a “natural buyer” for Staples but remain Buy rated anyway:

    Shares are higher on an unconfirmed WSJ report that SPLS is looking at the possible sale of the company. Our fundamentally valued 12-month target of $11, applies a below historical average P/E of 12.1X our FY 18 EPS estimate, given office industry challenges. Our target has 11% upside, plus a 5.5% yield. We don’t see a natural buyer for a large physical store office supply presence, although an activist/private-equity buyer is a possibility. To make an acquisition worthwhile, a buyer would have to be more aggressive in cost cutting and use of cash flow than SPLS’s existing plan.

    Staples’ market capitalization rose to $6.2 billion today from $5.7 billion yesterday. It reported a net loss of $459 million on sales of $18.2 billion in fiscal 2017.

Stocks to Watch: MannKind, Philips, TreeHouse Foods

Among the companies with shares expected to actively trade in Monday’s session are MannKind Corp.(MNKD), Philips NV(PHG) and TreeHouse Foods Inc.(THS)

The Food and Drug Administration on Friday approved a powder form of insulin, made by MannKind and known as Afrezza, which is inhaled instead of injected, to help diabetics control their blood sugar levels. MannKind shares jumped 11.8% to $11.18 premarket.

Philips said on Monday that it is spinning off its lighting components business in the latest stage of the once-diversified Dutch electronics group’s plan to focus on a handful of higher-margin activities. Philips said it would seek outside investors for its Lumileds Lighting unit, which it will combine with its automotive-lighting business. Shares rose 3.1% to $31.40 premarket.

TreeHouse Foods said that it agreed to buy private-label trail-mix maker Flagstone Foods for $860 million in cash. The move comes as TreeHouse has grown in recent quarters by buying up companies and expanding its portfolio. Shares rose 5.1% to $83.98 premarket.

Dicerna Pharmaceuticals Inc.(DRNA) announced the presentation of preclinical data demonstrating the promise of the company’s therapeutic candidate for the treatment of primary hyperoxaluria type 1, a rare inherited liver disorder that often results in progressive and severe kidney damage. Shares jumped 13% to $21.35 premarket.

Flamel Technologies SA(FLML) said the U.S. Food and Drug Administration has approved the company’s new drug application for Vazculep, an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. American depositary shares rose 5.1% to $14.78 in premarket trading.

Bebe Stores Inc.(BEBE) is exiting its value-oriented 2b concept and is cutting jobs as part of a cost-reduction program. The women’s apparel and accessories retailer said Friday that a workforce reduction affected about 9% of its nonstore employees, excluding the distribution center, and less than 1% of its store operations team.

Darden Restaurants Inc.(DRI) said Monday that it has launched a tender offer for as much as $600 million of its debt.

Consolidated Communications Holdings Inc.(CNSL) has agreed to acquire broadband communications provider Enventis Corp.(ENVE) in an all-stock deal that values Enventis at about $228 million. The deal values Enventis at about $16.50 a share, a 17% premium to Friday’s close.

HNI Corp.(HNI) said it plans to close its Midwest Folding Products facility as part of an ongoing cost-cutting effort. The Iowa office-furniture maker said it would consolidate the Chicago production into an existing education-furniture manufacturing facility and estimated it would save $2.3 million a year starting in 2015.

Kraton Performance Polymers Inc.’s(KRA) board is no longer pushing for the company’s stockholders to approve its plans to combine with LCY Chemical Corp.’s(1704.TW) styrenic block copolymer operations.

Martin Marietta Materials Inc.(MLM) will replace United States Steel Corp.(X) (X) in the Standard and Poor’s 500-stock index after the market closes July 1, according to S&P.

PPG Industries Inc.(PPG) agreed to acquire architectural and industrial coatings company Consorcio Comex SA for $2.3 billion. PPG Chief Executive Charles E. Bunch said the acquisition is complementary to the paint and coatings maker’s business.

Stryker Corp.(SYK) said Monday that it will acquire an ankle replacement system and other assets from Small Bone Innovations Inc. for up to $375 million in cash. The move aims to expand Stryker’s focus on orthopedics, the company said.

ResMed Inc.(RMD) seems like a solid growth stock, but March sales reportedly were aided by a quarter-end deal with a large customer, while profit was boosted by noncash accruals, according to Barron’s. The strains evident in march-quarter results may grow, if Medicare and other insurers decide to pay a bundled price for continuous positive airway pressure treatments. Shares slipped 3.8% to $50.49 in recent trading.

International Paper Co.(IP) is ramping up payouts and stock buybacks, according to Barron’s, which called the company a cash machine. With the debt from recent acquisitions now paid down to a comfortable level, the company is turning its attentions to returning more capital to shareholders. The company’s shares have been under pressure from unusual factors, from a weak ruble to bad weather, but the company looks poised to regain momentum as it continues to improve operations, expand margins, and use its enormous free cash flow for dividend increases and share buybacks. Some on Wall Street see the shares rising as high as $66 to $70 a share-as much as 43% higher-in the next 12 months, as strong demand leads to tighter supplies in the containerboard market, eventually leading to rising prices and substantial earnings growth.

With a free cash flow yield of 14%, NetApp Inc.(NTAP) is dirt cheap, according to Barron’s. NetApp shares have fallen from $50 three years ago to $35.48 recently, in part because revenue has decelerated fast enough to set off air bags: from 22% growth in fiscal 2012 to a projected decline of 0.4% for its current fiscal year, which runs through April. But profits remain rich, and there’s reason to believe NetApp will soon return to revenue growth. NetApp shares could rise more than 25% to $45 in the coming year. In a takeover they could fetch $50.